Management of Malignant Pleural Effusions in US Veterans: A Retrospective Review

被引:1
|
作者
Mohs, Zachary [1 ]
DeVillers, Megan [1 ]
Ziegler, Stephanie [1 ]
Basson, Marc D. [2 ,4 ]
Newman, William [1 ,3 ]
机构
[1] UND, Sch Med & Hlth Sci, Dept Internal Med, Grand Forks, ND USA
[2] UND, Sch Med & Hlth Sci, Dept Surg, Grand Forks, ND USA
[3] Fargo Vet Affairs Med Ctr, Dept Internal Med, Fargo, ND USA
[4] UND, Sch Med & Hlth Sci, Dept Surg, 1301 N Columbia Rd, Grand Forks, ND 58203 USA
关键词
talc pleurodesis; indwelling pleural catheter; malignant pleural effusion; TALC PLEURODESIS; CATHETER; DYSPNEA;
D O I
10.5761/atcs.oa.22-00124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To compare malignant pleural effusion (MPE) treatment outcomes and compli-cations among patients receiving indwelling pleural catheter (IPC), talc pleurodesis (TPS), or dual therapy. Outcomes were determined by measuring length of stay (LOS) and post-procedure dyspnea scores. Complications were measured by comparing intervention failures and adverse events.Methods: The Veterans Affairs' Corporate Data Warehouse was utilized to retrospectively review the charts of 314 MPE subjects. Dyspnea scores were estimated by researchers and LOS was determined by adding the duration of stay for all admissions post procedure. Complications were recorded through chart review.Results: IPC exhibited higher failure rates than the other approaches 1 year post inter-vention. Pneumonia/chest infection rate and lung entrapment were also more prevalent. There was no significant difference in dyspnea rates. LOS illustrated a significant differ-ence between groups, with talc patients spending a median of 7 days in the hospital immediately post procedure, while IPC and IPC + TPS patients spent a median of 3 and 2 days, respectively.Conclusion: Patients receiving IPC or combination treatment spend fewer days in the hospital than TPS patients. However, IPC appears to be associated with more adverse events and higher long-term failure rates than other management strategies.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 50 条
  • [41] Surgical Management of Malignant Pleural Effusions
    Murthy, Sudish C.
    Rice, Thomas W.
    THORACIC SURGERY CLINICS, 2013, 23 (01) : 43 - +
  • [42] Malignant Pleural Effusions: Management Options
    McCracken, David J.
    Porcel, Jose M.
    Rahman, Najib M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 39 (06) : 704 - 712
  • [43] Management of malignant pleural effusions and pneumothorax
    Erasmus, JJ
    Goodman, PC
    Patz, EF
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2000, 38 (02) : 375 - +
  • [44] Diagnosis and management of malignant pleural effusions
    Heffner, John E.
    RESPIROLOGY, 2008, 13 (01) : 5 - 20
  • [45] Comparing approaches to the management of malignant pleural effusions
    Porcel, Jose M.
    Lui, Macy Mei-Sze
    Lerner, Andrew D.
    Davies, Helen E.
    Feller-Kopman, David
    Lee, Y. C. Gary
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (04) : 273 - 284
  • [46] Current Controversies in the Management of Malignant Pleural Effusions
    Azzopardi, Maree
    Porcel, Jose M.
    Koegelenberg, Coenraad F. N.
    Lee, Y. C. Gary
    Fysh, Edward T. H.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (06) : 723 - 731
  • [47] Management of pleural effusions in children with malignant lymphoma
    Pietsch, JB
    Whitlock, JA
    Ford, C
    Kinney, MC
    JOURNAL OF PEDIATRIC SURGERY, 1999, 34 (04) : 635 - 638
  • [48] Preface Management of Benign and Malignant Pleural Effusions
    Choong, Cliff K. C.
    THORACIC SURGERY CLINICS, 2013, 23 (01) : IX - IX
  • [49] Advantages of indwelling pleural catheters for management of malignant pleural effusions
    Boshuizen, Rogier C.
    Thomas, Rajesh
    Lee, Y. C. Gary
    CURRENT PULMONOLOGY REPORTS, 2013, 2 (02) : 93 - 99
  • [50] Advantages of indwelling pleural catheters for management of malignant pleural effusions
    Rogier C. Boshuizen
    Rajesh Thomas
    Y. C. Gary Lee
    Current Respiratory Care Reports, 2013, 2 (2): : 93 - 99